Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084537 · ClinicalTrials.gov registry record · NA
Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Necrotizing Pancreatitis
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT02084537 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 69 participants.
The verdict
NCT02084537, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
Prospective, randomized controlled trial comparing Endoscopic Ultrasound (EUS) Guided cystogastrostomy or cystoduodenostomy and endoscopic necrosectomy to minimally invasive surgical necrosectomy, in patients with necrotizing pancreatitis.
Interventions
- PROCEDURE Endoscopic treatment
- PROCEDURE Minimally invasive surgical necrosectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084537
The ClinicalTrials.gov registry entry for NCT02084537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endoscopic treatment is the first listed.
NCT02084537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02084537 about?
NCT02084537 is a clinical study titled "Minimally Invasive Surgery vs. Endoscopy Randomized (MISER) Trial for Necrotizing Pancreatitis". Prospective, randomized controlled trial comparing Endoscopic Ultrasound (EUS) Guided cystogastrostomy or cystoduodenostomy and endoscopic necrosectomy to minimally invasive surgical necrosectomy, in patients with necrotizing pancreatitis.
What is the current status of trial NCT02084537?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2014-04. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02084537?
The interventions under investigation include: Endoscopic treatment (PROCEDURE), Minimally invasive surgical necrosectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02084537?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.